Related Experiment Video
Updated: Nov 30, 2025
09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
2.8K
Updates in Pediatric Glioma Pathology
Melanie H Hakar1, Matthew D Wood2
1Department of Pathology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, L-113, Portland, OR 97239, USA.
Surgical Pathology Clinics
|November 13, 2020
Summary
Pediatric glioma classification now integrates molecular features alongside histology for accurate diagnosis, treatment, and prognosis. This review highlights emerging concepts for pathologists to adopt molecular profiling in neuropathology.
Area of Science:
- Neuropathology
- Pediatric Oncology
- Molecular Diagnostics
Background:
- Gliomas are primary central nervous system tumors impacting pediatric patients.
- Accurate classification of gliomas is crucial for patient outcomes.
- Traditional classification relies on histology, but molecular alterations are increasingly recognized.
Purpose of the Study:
- To inform pediatric pathologists about new diagnostic concepts in glioma.
- To emphasize the integration of molecular features into glioma diagnosis.
- To highlight recent advancements in pediatric brain tumor classification.
Main Methods:
- Review of current literature on pediatric glioma classification.
- Focus on the role of molecular profiling in neuropathology.
- Integration of histological and molecular data for diagnosis.
Main Results:
- New categories of pediatric gliomas have emerged.
- Molecular profiling is essential for modern glioma classification.
- Combined histological and molecular data improve diagnostic accuracy.
Conclusions:
- Pediatric glioma diagnosis requires integrating molecular data with histology.
- Pathologists must adapt to new molecular-based diagnostic paradigms.
- This approach enhances diagnostic precision, treatment guidance, and prognostic assessment.
